The role of p21-activated kinase 4 in the progression of oral squamous cell carcinoma by targeting PI3K–AKT signaling pathway

被引：0
|
作者：
Lan Zhang
Shanfeng Lin
Zeying Zhang
Cong Yan
Fayu Liu
机构：
[1] China Medical University,Department of Oromaxillofacial
[2] Liaoning Provincial Key Laboratory of Oral Disease,Head and Neck Surgery, School and Hospital of Stomatology
[3] China Medical University,Nosocomial Infection Management Office, School and Hospital of Stomatology
[4] Liaoning Provincial Key Laboratory of Oral Diseases,Department of Endodontics, School and Hospital of Stomatology
[5] China Medical University,undefined
[6] Liaoning Provincial Key Laboratory of Oral Disease,undefined
来源：
Clinical and Translational Oncology | 2023年 / 25卷
关键词：
Oral squamous carcinoma; PAK4; P21-activated kinase 4; PI3K–AKT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：739 / 747
页数：8
相关论文
共 50 条
  • [1] The role of p21-activated kinase 4 in the progression of oral squamous cell carcinoma by targeting PI3K-AKT signaling pathway
    Zhang, Lan
    Lin, Shanfeng
    Zhang, Zeying
    Yan, Cong
    Liu, Fayu
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (03): : 739 - 747
  • [2] Knockdown of Metadherin suppressed the progression of oral squamous cell carcinoma via PI3K/AKT signaling pathway
    Ding, Z. Y.
    Dong, G.
    Yin, G.
    Yu, L. L.
    Li, W. X.
    Ding, B.
    [J]. JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2021, 35 (01): : 303 - 309
  • [3] The role of PI3K/AKT pathway in cell proliferation and apoptosis in oral Squamous Cell Carcinoma
    Ribeiro-Silva, A.
    Duarte, A.
    Silveira, G.
    [J]. VIRCHOWS ARCHIV, 2016, 469 : S116 - S116
  • [4] DKK2 promotes the progression of oral squamous cell carcinoma through the PI3K/AKT signaling pathway
    Guo, Wenbo
    Qu, Yun
    Yu, Yang
    Li, Xueming
    Liang, Zhuang
    Wang, Zhaoqi
    Hu, Tenglong
    Zhou, Shan
    [J]. AGING-US, 2024, 16 (10): : 9204 - 9215
  • [5] Integrin-α5 promoted the progression of oral squamous cell carcinoma and modulated PI3K/AKT signaling pathway
    Fan, Qing-Chun
    Tian, Hua
    Wang, Yan
    Liu, Xian-Bin
    [J]. ARCHIVES OF ORAL BIOLOGY, 2019, 101 : 85 - 91
  • [6] Targeting the PI3K/AKT/mTOR pathway in cutaneous squamous cell carcinoma
    Perry, Jay Ryan
    Thind, Amarinder Singh
    Minaei, Elahe
    Ryan, Emily
    Genenger, Benjamin
    Iyer, Gopal
    Martin, Carolan
    Ashford, Bruce
    Ranson, Andmarie
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 43 - 43
  • [7] p21-activated kinase 4 promotes the progression of esophageal squamous cell carcinoma by targeting LASP1
    Huang, Hui
    Xue, Qianqian
    Du, Xiaoge
    Cui, Jie
    Wang, Jing
    Cheng, Dan
    Li, Jiaqiong
    Zheng, Yaqiu
    Huang, Guojing
    Zhang, Keke
    Liu, Kangdong
    Lu, Jing
    Zhao, Jimin
    Chen, Xinhuan
    Dong, Ziming
    Li, Xiang
    [J]. MOLECULAR CARCINOGENESIS, 2021, 60 (01) : 38 - 50
  • [8] Imatinib inhibits oral squamous cell carcinoma by suppressing the PI3K/AKT/mTOR signaling pathway
    Ma, Lei
    Huang, Ke
    Zhang, Haibo
    Kim, Eungyung
    Kim, Hyeonjin
    Liu, Zhibin
    Kim, Chae Yeon
    Park, Kanghyun
    Raza, Muhammad Atif
    Kim, Kirim
    Yi, Junkoo
    Sung, Yonghun
    Ryoo, Zae Young
    Kim, Yong-Gun
    Kim, Myoung Ok
    [J]. JOURNAL OF CANCER, 2024, 15 (03): : 659 - 670
  • [9] Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck
    Simpson, Daniel R.
    Mell, Loren K.
    Cohen, Ezra E. W.
    [J]. ORAL ONCOLOGY, 2015, 51 (04) : 291 - 298
  • [10] The role of PI3K/AKT signaling pathway in gallbladder carcinoma
    Wu, Zeyu
    Yu, Xiao
    Zhang, Shuijun
    He, Yuting
    Guo, Wenzhi
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (07): : 4426 - 4442
12345